Direct and Indirect 5-HT Receptor Agonists Produce Gender-specific Effects on Locomotor and Vertical Activities in C57 BL/6J Mice

Overview

Journal Pharmacol Biochem Behav

Publisher Elsevier

Specialties Biochemistry
Pharmacology
Psychology
Social Sciences

Date 2009 Aug 25

PMID 19698737

Citations 19

Authors

Bethany R Brookshire

Sara R Jones

Affiliations

Soon will be listed here.

Abstract

It is well established that the dopamine (DA) and serotonin (5-HT) systems have extensive and complex interactions. However, the effects of specific 5-HT receptor agonists on traditionally DA-related behaviors remain unclear. Our goal in these studies was to characterize the effects of 5-HT receptor agonists on measures of locomotor activity and vertical rearing. The SSRIs fluoxetine and citalopram produced significant decreases in locomotor activity and vertical rearing at the highest doses used with females significantly more sensitive to citalopram. The 5-HT(1A) agonist 8-OH-DPAT and the 5-HT(2C) agonist MK 212 significantly decreased activity in both male and female mice, with females more sensitive to 8-OH-DPAT. In contrast, the 5-HT(1B) agonist RU 24969 and the 5-HT(2A) agonist DOI both increased activity, with DOI exhibiting differential effects with regard to sex. Finally, the 5-HT(3) agonist SR 57227 produced significant locomotor increases only in female mice at the lowest dose. The results of these experiments define locomotor profiles of several 5-HT agonists in male and female C57BL/6J mice, providing a foundation for further explorations of 5-HT receptor effects on activity.

Citing Articles

The role of brain serotonin signaling in excessive alcohol consumption and withdrawal: A call for more research in females.

Castle M, Flanigan M Neurobiol Stress. 2024; 30:100618.

PMID: 38433994 PMC: 10907856. DOI: 10.1016/j.ynstr.2024.100618.

Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics.

Jaster A, Gonzalez-Maeso J Mol Psychiatry. 2023; 28(9):3595-3612.

PMID: 37759040 PMC: 11078317. DOI: 10.1038/s41380-023-02274-x.

Tianeptine, but not fluoxetine, decreases avoidant behavior in a mouse model of early developmental exposure to fluoxetine.

Pekarskaya E, Holt E, Gingrich J, Ansorge M, Javitch J, Canetta S Sci Rep. 2021; 11(1):22852.

PMID: 34819526 PMC: 8613176. DOI: 10.1038/s41598-021-02074-9.

Effects of repeated treatment with the 5-HT and 5-HT agonists (R)-( +)-8-hydroxy-DPAT and CP-94253 on the locomotor activity and axillary temperatures of preweanling rats: evidence of tolerance and behavioral sensitization.

McDougall S, Taylor J, Roe M, Greenwood C Psychopharmacology (Berl). 2021; 239(2):413-427.

PMID: 34816290 DOI: 10.1007/s00213-021-06012-5.

Importance of dopaminergic neurotransmission for the RU 24969-induced locomotor activity of male and female rats during the preweanling period.

McDougall S, Montejano N, Park G, Robinson J Naunyn Schmiedebergs Arch Pharmacol. 2020; 394(5):903-913.

PMID: 33205248 PMC: 8106618. DOI: 10.1007/s00210-020-02011-z.

References

Kelly P . Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats. Brain Res. 1975; 100(1):163-9. DOI: 10.1016/0006-8993(75)90253-x. View

Stanford J, Currier T, Gerhardt G . Acute locomotor effects of fluoxetine, sertraline, and nomifensine in young versus aged Fischer 344 rats. Pharmacol Biochem Behav. 2002; 71(1-2):325-32. DOI: 10.1016/s0091-3057(01)00655-4. View

Schindler C, Carmona G . Effects of dopamine agonists and antagonists on locomotor activity in male and female rats. Pharmacol Biochem Behav. 2002; 72(4):857-63. DOI: 10.1016/s0091-3057(02)00770-0. View

Smith C . EFFECTS OF D-AMPHETAMINE UPON BRAIN AMINE CONTENT AND LOCOMOTOR ACTIVITY OF MICE. J Pharmacol Exp Ther. 1965; 147:96-102. View

Liang J, Wang X, Lu Y, Liu R, Zhang Q, Sun H . Effects of antidepressants on the exploration, spontaneous motor activity and isolation-induced aggressiveness in mice. Beijing Da Xue Xue Bao Yi Xue Ban. 2003; 35(1):54-60. View

Budygin E, Kilpatrick M, Gainetdinov R, Wightman R . Correlation between behavior and extracellular dopamine levels in rat striatum: comparison of microdialysis and fast-scan cyclic voltammetry. Neurosci Lett. 2000; 281(1):9-12. DOI: 10.1016/s0304-3940(00)00813-2. View

Walker E, Kohut S, Hass R, Brown Jr E, Prabandham A, Lefever T . Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice. Neuropharmacology. 2005; 49(8):1210-9. DOI: 10.1016/j.neuropharm.2005.07.015. View

ODell L, Manzardo A, Polis I, Stouffer D, Parsons L . Biphasic alterations in serotonin-1B (5-HT1B) receptor function during abstinence from extended cocaine self-administration. J Neurochem. 2006; 99(5):1363-76. DOI: 10.1111/j.1471-4159.2006.04163.x. View

Alex K, Pehek E . Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther. 2006; 113(2):296-320. PMC: 2562467. DOI: 10.1016/j.pharmthera.2006.08.004. View

10.

Dulawa S, Holick K, Gundersen B, Hen R . Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology. 2004; 29(7):1321-30. DOI: 10.1038/sj.npp.1300433. View

11.

Crowley J, Blendy J, Lucki I . Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berl). 2005; 183(2):257-64. DOI: 10.1007/s00213-005-0166-5. View

12.

Yoo J, Cho J, Yu H, Lee K, Lee B, Jeong S . Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study. J Neurochem. 2006; 99(3):976-88. DOI: 10.1111/j.1471-4159.2006.04137.x. View

13.

Robinson T, Becker J, Presty S . Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res. 1982; 253(1-2):231-41. DOI: 10.1016/0006-8993(82)90690-4. View

14.

Campbell A, Kohl R, McBride W . Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release. Alcohol. 1996; 13(6):569-74. DOI: 10.1016/s0741-8329(96)00069-9. View

15.

Brocco M, Dekeyne A, Veiga S, Girardon S, Millan M . Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacol Biochem Behav. 2002; 71(4):667-80. DOI: 10.1016/s0091-3057(01)00701-8. View

16.

Zhang L, Ma W, Barker J, Rubinow D . Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neuroscience. 1999; 94(1):251-9. DOI: 10.1016/s0306-4522(99)00234-1. View

17.

Berridge C . Neural substrates of psychostimulant-induced arousal. Neuropsychopharmacology. 2006; 31(11):2332-40. DOI: 10.1038/sj.npp.1301159. View

18.

Minabe Y, Ashby Jr C, Wang R . The effect of acute and chronic LY 277359, a selective 5-HT3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons. Eur J Pharmacol. 1991; 209(3):151-6. DOI: 10.1016/0014-2999(91)90163-k. View

19.

Murphy N, Lam H, Maidment N . A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice. J Neurochem. 2001; 79(3):626-35. DOI: 10.1046/j.1471-4159.2001.00599.x. View

20.

Chaouloff F, Courvoisier H, Moisan M, Mormede P . GR 127935 reduces basal locomotor activity and prevents RU 24969-, but not D-amphetamine-induced hyperlocomotion, in the Wistar-Kyoto hyperactive (WKHA) rat. Psychopharmacology (Berl). 1999; 141(3):326-31. DOI: 10.1007/s002130050841. View